Literature DB >> 11498590

Coordination of a transcriptional switch by HMGI(Y) acetylation.

N Munshi1, T Agalioti, S Lomvardas, M Merika, G Chen, D Thanos.   

Abstract

Dynamic control of interferon-beta (IFN-beta) gene expression requires the regulated assembly and disassembly of the enhanceosome, a higher-order nucleoprotein complex formed in response to virus infection. The enhanceosome activates transcription by recruiting the histone acetyltransferase proteins CREB binding protein (CBP) and p300/CBP-associated factors (PCAF)/GCN5, which, in addition to modifying histones, acetylate HMGI(Y), the architectural component required for enhanceosome assembly. We show that the accurate execution of the IFN-beta transcriptional switch depends on the ordered acetylation of the high-mobility group I protein HMGI(Y) by PCAF/GCN5 and CBP, which acetylate HMGI(Y) at distinct lysine residues on endogenous promoters. Whereas acetylation of HMGI(Y) by CBP at lysine-65 destabilizes the enhanceosome, acetylation of HMGI(Y) by PCAF/GCN5 at lysine-71 potentiates transcription by stabilizing the enhanceosome and preventing acetylation by CBP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498590     DOI: 10.1126/science.293.5532.1133

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  65 in total

1.  Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5.

Authors:  Anne Rascle; James A Johnston; Bruno Amati
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity.

Authors:  Chao-Zhong Song; Kimberly Keller; Yangchao Chen; George Stamatoyannopoulos
Journal:  J Mol Biol       Date:  2003-05-30       Impact factor: 5.469

3.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

4.  cis-regulatory logic of short-range transcriptional repression in Drosophila melanogaster.

Authors:  Meghana M Kulkarni; David N Arnosti
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.

Authors:  Hui Song; Chia-Wei Li; Adam M Labaff; Seung-Oe Lim; Long-Yuan Li; Shu-Fen Kan; Yue Chen; Kai Zhang; Jingyu Lang; Xiaoming Xie; Yan Wang; Long-Fei Huo; Sheng-Chieh Hsu; Xiaomin Chen; Yingming Zhao; Mien-Chie Hung
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

Review 6.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

7.  An atomic model of the interferon-beta enhanceosome.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

8.  HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.

Authors:  Isabelle Bouallaga; Sébastien Teissier; Moshe Yaniv; Françoise Thierry
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Opposite orientations of a transcription factor heterodimer bind DNA cooperatively with interaction partners but have different effects on interferon-β gene transcription.

Authors:  Veronica Burns; Tom Klaus Kerppola
Journal:  J Biol Chem       Date:  2012-07-27       Impact factor: 5.157

10.  Regulation of human SRY subcellular distribution by its acetylation/deacetylation.

Authors:  Laurie Thevenet; Catherine Méjean; Brigitte Moniot; Nathalie Bonneaud; Nathalie Galéotti; Gudrun Aldrian-Herrada; Francis Poulat; Philippe Berta; Monsef Benkirane; Brigitte Boizet-Bonhoure
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.